To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

NCT00986882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: SAF312A
DRUG: Placebo
DRUG: Ibuprofen

Sponsor

Novartis